SEC 13F Intelligence

Foresite Capital Management IV, LLC / IMMU

Foresite Capital Management IV, LLC’s Immunomedics Inc Position

Does Foresite Capital Management IV, LLC own Immunomedics Inc (IMMU)? Not currently — the last reported position was 367.6K shares worth $5M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q3 2019
Shares
367.6K
% of Portfolio
+1.58%
Quarters Held
3
position exited

Position History IMMU

Reported value by quarter
Q1 ’19: $22MQ1 ’19Q2 ’19: $5MQ2 ’19Q3 ’19: $5MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019367.6K$5M+1.58%
Q2 2019385.8K$5M+1.51%
Q1 20191.16M$22M+8.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of IMMU.